Published in J Control Release on September 18, 2010
Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging. Biomaterials (2012) 1.27
Iron oxide nanoparticle-based magnetic resonance method to monitor release kinetics from polymeric particles with high resolution. Anal Chem (2012) 0.88
Functional polymers in protein detection platforms: optical, electrochemical, electrical, mass-sensitive, and magnetic biosensors. Sensors (Basel) (2011) 0.83
Bio-responsive polymer hydrogels homeostatically regulate blood coagulation. Nat Commun (2013) 0.80
pH-Sensitive polymeric micelle-based pH probe for detecting and imaging acidic biological environments. Biomacromolecules (2012) 0.75
Poly-beta-amino-esters nano-vehicles based drug delivery system for cartilage. Nanomedicine (2016) 0.75
Block Copolymer-Encapsulated CaWO4 Nanoparticles: Synthesis, Formulation, and Characterization. ACS Appl Mater Interfaces (2016) 0.75
Intelligent recognitive systems in nanomedicine. Curr Opin Chem Eng (2014) 0.75
Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med (2015) 4.27
First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung. J Clin Oncol (2012) 3.90
Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations. NMR Biomed (2004) 2.74
Management of dilated ascending aorta during aortic valve replacement: valve replacement alone versus aorta wrapping versus aorta replacement. J Thorac Cardiovasc Surg (2013) 2.73
Laparoendoscopic single-site surgery in urology: worldwide multi-institutional analysis of 1076 cases. Eur Urol (2011) 2.46
Outcomes of patients with acute type a aortic intramural hematoma. Circulation (2009) 2.37
Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression. Clin Cancer Res (2008) 2.31
siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev (2009) 2.21
Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem Int Ed Engl (2007) 2.19
Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J Control Release (2008) 2.15
Right or left anterolateral minithoracotomy for repair of congenital ventricular septal defects in adult patients. Interact Cardiovasc Thorac Surg (2009) 2.14
Clinical and echocardiographic outcomes after surgery for severe isolated tricuspid regurgitation. J Thorac Cardiovasc Surg (2012) 2.11
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial. Lancet Oncol (2012) 1.98
Long-term predictors of descending aorta aneurysmal change in patients with aortic dissection. J Am Coll Cardiol (2007) 1.97
Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma. Leuk Lymphoma (2009) 1.83
Thermally triggered intracellular explosion of volume transition nanogels for necrotic cell death. J Control Release (2008) 1.77
All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew Chem Int Ed Engl (2009) 1.77
Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release (2004) 1.71
siRNA conjugate delivery systems. Bioconjug Chem (2009) 1.69
Defining functional SMA and pre-SMA subregions in human MFC using resting state fMRI: functional connectivity-based parcellation method. Neuroimage (2009) 1.69
In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. J Control Release (2008) 1.67
Total arch repair versus hemiarch repair in the management of acute DeBakey type I aortic dissection. Eur J Cardiothorac Surg (2011) 1.61
Long-term outcome of modified maze procedure combined with mitral valve surgery: analysis of outcomes according to type of mitral valve surgery. J Thorac Cardiovasc Surg (2009) 1.61
Geometric changes after tricuspid annuloplasty and predictors of residual tricuspid regurgitation: a real-time three-dimensional echocardiography study. Eur Heart J (2010) 1.59
Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J Control Release (2004) 1.59
Long-term outcomes after surgery for rheumatic mitral valve disease: valve repair versus mechanical valve replacement. Eur J Cardiothorac Surg (2009) 1.55
Neovascularization precedes occlusion in moyamoya disease: angiographic findings in 172 pediatric patients. Eur Neurol (2014) 1.54
Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy. Angew Chem Int Ed Engl (2006) 1.54
Analysis of recurrent mitral regurgitation after mitral valve repair. Asian Cardiovasc Thorac Ann (2005) 1.52
Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing. Nat Mater (2010) 1.50
Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery. Adv Drug Deliv Rev (2009) 1.50
Descending aortic aneurysmal changes following surgery for acute DeBakey type I aortic dissection. Eur J Cardiothorac Surg (2012) 1.49
MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles. Magn Reson Med (2008) 1.46
PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. J Control Release (2006) 1.44
Novel technique of aortic valvuloplasty. Eur J Cardiothorac Surg (2006) 1.44
Surgical outcomes of severe tricuspid regurgitation: predictors of adverse clinical outcomes. Heart (2012) 1.43
Propensity-matched comparison of drug-eluting stent implantation and coronary artery bypass graft surgery in chronic hemodialysis patients. J Nephrol (2013) 1.41
Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group. J Pediatr Hematol Oncol (2003) 1.40
Inclusion of hemoglobin level in prognostic score provides better prognostic stratification in patients with acute promyelocytic leukemia (APL). Int J Hematol (2013) 1.39
Can carotid endarterectomy improve metabolic status in patients with asymptomatic internal carotid artery flow lesion? Studies with localized in vivo proton magnetic resonance spectroscopy. J Vasc Surg (2002) 1.38
Wrap-bake-peel process for nanostructural transformation from beta-FeOOH nanorods to biocompatible iron oxide nanocapsules. Nat Mater (2008) 1.36
Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. Biomaterials (2009) 1.34
Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery. Angew Chem Int Ed Engl (2009) 1.34
Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. J Control Release (2004) 1.34
Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. Langmuir (2005) 1.32
Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv Drug Deliv Rev (2007) 1.28
OutlierD: an R package for outlier detection using quantile regression on mass spectrometry data. Bioinformatics (2008) 1.25
Injectable biodegradable hydrogels. Macromol Biosci (2010) 1.24
Measurement and automatic correction of high-order B0 inhomogeneity in the rat brain at 11.7 Tesla. Magn Reson Imaging (2004) 1.24
Biomimicking extracellular matrix: cell adhesive RGD peptide modified electrospun poly(D,L-lactic-co-glycolic acid) nanofiber mesh. Tissue Eng (2006) 1.22
MR mismatch profiles in patients with intracranial atherosclerotic stroke: a comprehensive approach comparing stroke subtypes. J Cereb Blood Flow Metab (2009) 1.20
The prognosis of liver cirrhosis in recent years in Korea. J Korean Med Sci (2003) 1.20
Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J Control Release (2007) 1.20
Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study. Stroke (2009) 1.20
Laparoendoscopic single-site surgeries: a single-center experience of 171 consecutive cases. Korean J Urol (2011) 1.20
Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging. Biomaterials (2011) 1.18
Heparin-coated gold nanoparticles for liver-specific CT imaging. Chemistry (2009) 1.17
Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice. J Control Release (2009) 1.17
Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy. Bioconjug Chem (2010) 1.16
Bioinspired synthesis and characterization of gadolinium-labeled magnetite nanoparticles for dual contrast t1- and t2-weighted magnetic resonance imaging. Bioconjug Chem (2010) 1.14
Gas foamed open porous biodegradable polymeric microspheres. Biomaterials (2006) 1.14
In vivo 13C magnetic resonance spectroscopy of human brain on a clinical 3 T scanner using [2-13C]glucose infusion and low-power stochastic decoupling. Magn Reson Med (2009) 1.14
High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Ann Hematol (2010) 1.13
Novel strategy for cerebral 13C MRS using very low RF power for proton decoupling. Magn Reson Med (2007) 1.13
Amine-functionalized gold nanoparticles as non-cytotoxic and efficient intracellular siRNA delivery carriers. Int J Pharm (2008) 1.13
Effect of data normalization on fuzzy clustering of DNA microarray data. BMC Bioinformatics (2006) 1.11
Survival analysis of orthodontic mini-implants. Am J Orthod Dentofacial Orthop (2010) 1.11
Hyaluronic acid modified biodegradable scaffolds for cartilage tissue engineering. Biomaterials (2005) 1.11
Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity. Bioconjug Chem (2008) 1.11
Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results. AJNR Am J Neuroradiol (2005) 1.10
Bioinspired Surface Immobilization of Hyaluronic Acid on Monodisperse Magnetite Nanocrystals for Targeted Cancer Imaging. Adv Mater (2008) 1.09
Novel pH sensitive block copolymer micelles for solvent free drug loading. Macromol Biosci (2006) 1.08
Novel epitheliomesenchymal biphasic stomach tumour (gastroblastoma) in a 9-year-old: morphological, ultrastructural and immunohistochemical findings. J Clin Pathol (2010) 1.08
Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages. J Control Release (2002) 1.07
Intracellular trafficking and unpacking of siRNA/quantum dot-PEI complexes modified with and without cell penetrating peptide: confocal and flow cytometric FRET analysis. Bioconjug Chem (2010) 1.07
Mitral valve repair versus replacement for moderate-to-severe mitral regurgitation in patients undergoing concomitant aortic valve replacement. Interact Cardiovasc Thorac Surg (2013) 1.07
Metabolomic approach for age discrimination of Panax ginseng using UPLC-Q-Tof MS. J Agric Food Chem (2011) 1.06
Initial clinical experience of simultaneous robot-assisted bilateral partial nephrectomy and radical prostatectomy. Yonsei Med J (2012) 1.05
Nanomaterials for cancer therapy and imaging. Mol Cells (2011) 1.05
Catechol-functionalized chitosan/pluronic hydrogels for tissue adhesives and hemostatic materials. Biomacromolecules (2011) 1.04
Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy. J Control Release (2007) 1.03
PEGylated and MMP-2 specifically dePEGylated quantum dots: comparative evaluation of cellular uptake. Langmuir (2009) 1.03
Usefulness of the dynamic gadolinium-enhanced magnetic resonance imaging with simultaneous acquisition of coronal and sagittal planes for detection of pituitary microadenomas. Eur Radiol (2011) 1.03
Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA. Biopolymers (2008) 1.02
Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock. J Control Release (2007) 1.02
Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int J Cancer (2005) 1.02
Detection of cortical laminar architecture using manganese-enhanced MRI. J Neurosci Methods (2007) 1.02
Substrate-Independent Layer-by-Layer Assembly by Using Mussel-Adhesive-Inspired Polymers. Adv Mater (2008) 1.02
Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery. Pharm Res (2006) 1.01
Metabolic alterations in focally activated primary somatosensory cortex of alpha-chloralose-anesthetized rats measured by 1H MRS at 11.7 T. Neuroimage (2005) 1.01
Surgical Outcomes of Congenital Atrial Septal Defect Using da VinciTM Surgical Robot System. Korean J Thorac Cardiovasc Surg (2013) 1.01
Left atrial ablation versus biatrial ablation in the surgical treatment of atrial fibrillation. Ann Thorac Surg (2011) 1.01
Controlled release of plasmid DNA from photo-cross-linked pluronic hydrogels. Biomaterials (2005) 1.01
Tumoral acidic pH-responsive MPEG-poly(beta-amino ester) polymeric micelles for cancer targeting therapy. J Control Release (2010) 1.01
Macroporous poly(L-lactide) scaffold 1. Preparation of a macroporous scaffold by liquid--liquid phase separation of a PLLA--dioxane--water system. J Biomed Mater Res (2002) 1.00
Biodegradable PLGA microcarriers for injectable delivery of chondrocytes: effect of surface modification on cell attachment and function. Biotechnol Prog (2004) 1.00